These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18468556)

  • 21. Zebrafish: a complete animal model for in vivo drug discovery and development.
    Chakraborty C; Hsu CH; Wen ZH; Lin CS; Agoramoorthy G
    Curr Drug Metab; 2009 Feb; 10(2):116-24. PubMed ID: 19275547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ZeGlobalTox: An Innovative Approach to Address Organ Drug Toxicity Using Zebrafish.
    Cornet C; Calzolari S; Miñana-Prieto R; Dyballa S; van Doornmalen E; Rutjes H; Savy T; D'Amico D; Terriente J
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Zebrafish in Drug Discovery Toxicology.
    Cassar S; Adatto I; Freeman JL; Gamse JT; Iturria I; Lawrence C; Muriana A; Peterson RT; Van Cruchten S; Zon LI
    Chem Res Toxicol; 2020 Jan; 33(1):95-118. PubMed ID: 31625720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding dioxin developmental toxicity using the zebrafish model.
    Carney SA; Prasch AL; Heideman W; Peterson RE
    Birth Defects Res A Clin Mol Teratol; 2006 Jan; 76(1):7-18. PubMed ID: 16333842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zebrafish: a preclinical model for drug screening.
    Parng C; Seng WL; Semino C; McGrath P
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):41-8. PubMed ID: 15090155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Zebrafish as a model organism for biomedical studies].
    Beliaeva NF; Kashirtseva VN; Medvedeva NV; Khudoklinova IuIu; Ipatova OM; Archakov AI
    Biomed Khim; 2010; 56(1):120-31. PubMed ID: 21328916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zebrafish assays as early safety pharmacology screens: paradigm shift or red herring?
    Redfern WS; Waldron G; Winter MJ; Butler P; Holbrook M; Wallis R; Valentin JP
    J Pharmacol Toxicol Methods; 2008; 58(2):110-7. PubMed ID: 18603451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity.
    Fako VE; Furgeson DY
    Adv Drug Deliv Rev; 2009 Jun; 61(6):478-86. PubMed ID: 19389433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zebrafish: as an integrative model for twenty-first century toxicity testing.
    Sipes NS; Padilla S; Knudsen TB
    Birth Defects Res C Embryo Today; 2011 Sep; 93(3):256-67. PubMed ID: 21932434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using Zebrafish for Investigating the Molecular Mechanisms of Drug-Induced Cardiotoxicity.
    Zakaria ZZ; Benslimane FM; Nasrallah GK; Shurbaji S; Younes NN; Mraiche F; Da'as SI; Yalcin HC
    Biomed Res Int; 2018; 2018():1642684. PubMed ID: 30363733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zebrafish and cardiac toxicology.
    Heideman W; Antkiewicz DS; Carney SA; Peterson RE
    Cardiovasc Toxicol; 2005; 5(2):203-14. PubMed ID: 16046794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zebrafish: an emerging model system for human disease and drug discovery.
    Kari G; Rodeck U; Dicker AP
    Clin Pharmacol Ther; 2007 Jul; 82(1):70-80. PubMed ID: 17495877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons between in vitro whole cell imaging and in vivo zebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development.
    Hill A; Mesens N; Steemans M; Xu JJ; Aleo MD
    Drug Metab Rev; 2012 Feb; 44(1):127-40. PubMed ID: 22242931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicity assessment of 7 anticancer compounds in zebrafish.
    Gao XP; Feng F; Zhang XQ; Liu XX; Wang YB; She JX; He ZH; He MF
    Int J Toxicol; 2014; 33(2):98-105. PubMed ID: 24563414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a zebrafish embryo teratogenicity assay and quantitative prediction model.
    Brannen KC; Panzica-Kelly JM; Danberry TL; Augustine-Rauch KA
    Birth Defects Res B Dev Reprod Toxicol; 2010 Feb; 89(1):66-77. PubMed ID: 20166227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zebrafish (Danio rerio) as a model organism for investigating endocrine disruption.
    Segner H
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Mar; 149(2):187-95. PubMed ID: 18955160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fishing for teratogens: a consortium effort for a harmonized zebrafish developmental toxicology assay.
    Ball JS; Stedman DB; Hillegass JM; Zhang CX; Panzica-Kelly J; Coburn A; Enright BP; Tornesi B; Amouzadeh HR; Hetheridge M; Gustafson AL; Augustine-Rauch KA
    Toxicol Sci; 2014 May; 139(1):210-9. PubMed ID: 24496635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A category approach to predicting the developmental (neuro) toxicity of organotin compounds: the value of the zebrafish (Danio rerio) embryotoxicity test (ZET).
    Beker van Woudenberg A; Wolterbeek A; Te Brake L; Snel C; Menke A; Rubingh C; de Groot D; Kroese D
    Reprod Toxicol; 2013 Nov; 41():35-44. PubMed ID: 23796951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zebrafish embryos and larvae: a new generation of disease models and drug screens.
    Ali S; Champagne DL; Spaink HP; Richardson MK
    Birth Defects Res C Embryo Today; 2011 Jun; 93(2):115-33. PubMed ID: 21671352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a new screening assay to identify proteratogenic substances using zebrafish danio rerio embryo combined with an exogenous mammalian metabolic activation system (mDarT).
    Busquet F; Nagel R; von Landenberg F; Mueller SO; Huebler N; Broschard TH
    Toxicol Sci; 2008 Jul; 104(1):177-88. PubMed ID: 18375544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.